News & Updates

Show Multimedia Only

5-year survival more likely in mBCC patients with nodal vs distant metastasis

21 Feb 2024

Among patients with metastatic basal cell carcinoma (mBCC), those with nodal disease appear to have a higher chance of remission, while individuals with distant metastasis tend to have persistent disease and subsequently die from it, a recent study reveals. However, the survival rates at 5 years surpass 50 percent even for those with stage IV disease.

5-year survival more likely in mBCC patients with nodal vs distant metastasis

21 Feb 2024

Patch test a boon to dupilumab-treated patients

21 Feb 2024

A prospective, multicentre study has demonstrated the efficacy of patch tests (PTs) for patients who are being treated with dupilumab.

Patch test a boon to dupilumab-treated patients

21 Feb 2024

Smoking raises risk of death in early-stage melanoma

13 Feb 2024

Smokers who have received a diagnosis of early-stage melanoma are at increased risk of death, according to a study.

Smoking raises risk of death in early-stage melanoma

13 Feb 2024

Oil palm pollen exposure may trigger, aggravate allergic diseases in Asians

07 Feb 2024 by

Exposure to oil palm pollen poses a heightened risk of developing diseases such as asthma and allergic rhinitis in Asians or risk of exacerbations in those who have these diseases already, according to a study.

Oil palm pollen exposure may trigger, aggravate allergic diseases in Asians

07 Feb 2024

Long-term steroid-free pemphigus remission achieved with frontline rituximab

28 Jan 2024 by

First-line treatment with rituximab appears to induce durable remission in patients with pemphigus, and this is achieved without corticosteroid therapy and any additional maintenance infusion of rituximab.

Long-term steroid-free pemphigus remission achieved with frontline rituximab

28 Jan 2024

Dupilumab delivers on its promise for Asians with atopic dermatitis

25 Jan 2024 by

Singaporeans who have been treated with dupilumab in real-world clinical setting achieve improvements in the signs and symptoms of moderate-to-severe atopic dermatitis, as shown in a retrospective study.

Dupilumab delivers on its promise for Asians with atopic dermatitis

25 Jan 2024

Isotretinoin use carries no risk of self-harm

23 Jan 2024

Isotretinoin users do not appear to have an elevated risk of self-harm, with the risk of suicide attempts being lower at 2 to 4 years after treatment, according to the results of a meta-analysis.

Isotretinoin use carries no risk of self-harm

23 Jan 2024

Delayed postoperative radiation tied to higher recurrence, death in MCC

23 Jan 2024

Delays in postoperative radiation therapy (PORT) may lead to increased locoregional recurrence (LRR), usually occurring beyond the radiation field, among patients with Merkel cell carcinoma (MCC), as shown in a recent study.

Delayed postoperative radiation tied to higher recurrence, death in MCC

23 Jan 2024

Berdazimer gel reduces molluscum contagiosum lesions in children

22 Jan 2024 by

An analysis of three randomized controlled trials (RCTs) has shown the efficacy and safety of berdazimer gel, a topical, antiviral, nitric oxide-releasing medication, in the treatment of molluscum contagiosum (MC) lesions in patients aged 6 months and older. Application-site pain and erythema are the most common adverse events (AEs) related to treatment.

Berdazimer gel reduces molluscum contagiosum lesions in children

22 Jan 2024

Original New Drug Application Approvals by US FDA (01-15 January 2024)

18 Jan 2024

New drug applications approved by US FDA as of 01-15 January 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 January 2024)

18 Jan 2024

News & Updates

Showing Dermatology articles

Showing

Specialty:

5-year survival more likely in mBCC patients with nodal vs distant metastasis

5-year survival more likely in mBCC patients with nodal vs distant metastasis

Patch test a boon to dupilumab-treated patients

Patch test a boon to dupilumab-treated patients

Smoking raises risk of death in early-stage melanoma

Smoking raises risk of death in early-stage melanoma

Oil palm pollen exposure may trigger, aggravate allergic diseases in Asians

Oil palm pollen exposure may trigger, aggravate allergic diseases in Asians

Long-term steroid-free pemphigus remission achieved with frontline rituximab

Long-term steroid-free pemphigus remission achieved with frontline rituximab

Dupilumab delivers on its promise for Asians with atopic dermatitis

Dupilumab delivers on its promise for Asians with atopic dermatitis

Isotretinoin use carries no risk of self-harm

Isotretinoin use carries no risk of self-harm

Delayed postoperative radiation tied to higher recurrence, death in MCC

Delayed postoperative radiation tied to higher recurrence, death in MCC

Berdazimer gel reduces molluscum contagiosum lesions in children

Berdazimer gel reduces molluscum contagiosum lesions in children

Original New Drug Application Approvals by US FDA (01-15 January 2024)

Original New Drug Application Approvals by US FDA (01-15 January 2024)